Data on Breast Cancer Reported by a Researcher at Department of Obstetrics and Gynecology (The Impact of Tamoxifen Usage in Breast Cancer Patients on the Development of Histopathological Lesions in the Cervix Uteri).

A recent study conducted in Osmaniye, Turkey compared the results of colposcopic biopsies in breast cancer patients and individuals who tested positive for HPV in cervix uteri cytological screenings. The study aimed to investigate the impact of tamoxifen treatment, an anti-estrogen drug used in breast cancer treatment, on histopathological changes. The study found that tamoxifen treatment did not lead to an increase in abnormal histological changes in the cervix uteri. The researchers concluded that gynecological examination and cervical cytological screening should be advised for all breast cancer cases. [Extracted from the article]